2,342 Shares in CME Group Inc. $CME Bought by Evansbrook LLC

Evansbrook LLC purchased a new stake in CME Group Inc. (NASDAQ:CME) during the 4th quarter, HoldingsChannel reports. The firm purchased 2,342 shares of the financial services provider’s stock, valued at approximately $640,000.

Several other institutional investors have also added to or reduced their stakes in the stock. Empowered Funds LLC lifted its position in shares of CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the period. Marshall Wace LLP lifted its holdings in CME Group by 103.1% in the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after buying an additional 121,707 shares during the period. Federated Hermes Inc. boosted its position in CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after acquiring an additional 21,918 shares in the last quarter. Nebula Research & Development LLC bought a new stake in CME Group during the 2nd quarter valued at approximately $992,000. Finally, The Manufacturers Life Insurance Company grew its holdings in shares of CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after acquiring an additional 7,397 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by insiders.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Neutral Sentiment: CME announced a planned CEO succession: longtime chief Terry Duffy will step down in March 2027 and transition to executive chairman, while President and CFO Lynne Fitzpatrick will become CEO. The move also makes Fitzpatrick CME’s first woman chief executive, which supports continuity but adds some near-term uncertainty around the handoff. Article Title
• Neutral Sentiment: The company also highlighted its long-term leadership change in multiple interviews and reports, which may reassure investors that the transition is orderly rather than sudden. Article Title
• Negative Sentiment: CME said it plans to sue the CFTC over approval of crypto perpetual futures, arguing the regulator is improperly treating these products as swaps rather than futures. The legal fight raises regulatory risk and could create uncertainty around CME’s crypto derivatives strategy. Article Title
• Negative Sentiment: Several headlines repeated the lawsuit plan, suggesting the issue is the main driver of today’s weakness as investors focus on possible friction with regulators and the implications for future product approvals. Article Title

Analysts Set New Price Targets

CME has been the subject of a number of research analyst reports. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Saturday, June 13th. Argus reaffirmed a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research report on Thursday. Finally, Weiss Ratings lowered CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, June 11th. Twelve investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $305.18.

CME Group Price Performance

Shares of CME opened at $246.38 on Friday. CME Group Inc. has a fifty-two week low of $244.56 and a fifty-two week high of $329.16. The firm’s 50-day simple moving average is $280.74 and its two-hundred day simple moving average is $287.50. The stock has a market cap of $89.28 billion, a PE ratio of 21.02, a price-to-earnings-growth ratio of 2.82 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period last year, the business earned $2.80 earnings per share. The business’s revenue was up 14.5% on a year-over-year basis. Analysts anticipate that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.